180 related articles for article (PubMed ID: 37248461)
21. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
[TBL] [Abstract][Full Text] [Related]
22. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma.
Kim BY; Choi N; Kim SW; Jeong HS; Chung MK; Son YI
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):569-576. PubMed ID: 31664515
[TBL] [Abstract][Full Text] [Related]
24. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
Wang ZH; Zhang YJ; Fu GM; Chen YB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
[No Abstract] [Full Text] [Related]
26. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma.
Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ
Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
Huang H; Xu Z; Wang X; Wu Y; Liu S
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
[TBL] [Abstract][Full Text] [Related]
29. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
31. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma.
Caliskan M; Park JH; Jeong JS; Lee CR; Park SK; Kang SW; Jeong JJ; Chung WY; Park CS
Endocr J; 2012; 59(4):305-11. PubMed ID: 22240889
[TBL] [Abstract][Full Text] [Related]
32. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
Gui CY; Qiu SL; Peng ZH; Wang M
J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
[TBL] [Abstract][Full Text] [Related]
33. Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma.
Lee J; Song Y; Soh EY
J Korean Med Sci; 2014 Jan; 29(1):48-52. PubMed ID: 24431905
[TBL] [Abstract][Full Text] [Related]
34. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
So YK; Seo MY; Son YI
Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
37. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients].
Li XJ; Yang L; Ma BL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):52-57. PubMed ID: 29774686
[No Abstract] [Full Text] [Related]
38. Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma.
Zhang C; Li BJ; Liu Z; Wang LL; Cheng W
Eur Arch Otorhinolaryngol; 2020 Apr; 277(4):1191-1198. PubMed ID: 31932880
[TBL] [Abstract][Full Text] [Related]
39. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
[TBL] [Abstract][Full Text] [Related]
40. Effect of Prophylactic Central Lymph Node Dissection on Locoregional Recurrence in Patients with Papillary Thyroid Microcarcinoma.
Yang P; Li J; Jing H; Chen Q; Song X; Qian L
Int J Endocrinol; 2021; 2021():8270622. PubMed ID: 34819955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
